CV Sciences (CVSI) Gross Profit Growth (5y) (2018 - 2026)
CV Sciences (CVSI) Gross Profit Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.73% |
| Mar 31, 2026 | -7.91% |
| Dec 31, 2025 | -5.53% |
| Sep 30, 2025 | -8.47% |
| Jun 30, 2025 | -4.51% |
| Mar 31, 2025 | -16.18% |
| Dec 31, 2024 | -16.57% |
| Sep 30, 2024 | -26.74% |
| Jun 30, 2024 | -31.07% |
| Mar 31, 2024 | -29.39% |
| Dec 31, 2023 | -28.48% |
| Sep 30, 2023 | -28.62% |
| Jun 30, 2023 | -28.29% |
| Mar 31, 2023 | -20.36% |
| Dec 31, 2022 | -21.42% |
| Sep 30, 2022 | -17.13% |
| Jun 30, 2022 | -14.89% |
| Mar 31, 2022 | -13.83% |
| Dec 31, 2021 | -2.41% |
| Sep 30, 2021 | 4.54% |